April 6, 2022 01:39 PM EDT
Pharma
Manufacturing
Law

Co-founder of Flori­da phar­ma in­dict­ed af­ter mul­ti­state bac­te­r­i­al out­break at chil­dren's hos­pi­tals

Josh Sullivan

The for­mer CEO of a Flori­da phar­ma has been charged with de­fraud­ing the FDA and dis­trib­ut­ing adul­ter­at­ed drugs by the US …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

A service from the Financial Times